Mode
Text Size
Log in / Sign up
N/A N=60 Double-blind Treatment

Impact of Intensive Social Interaction on Post-Stroke Depression in Individuals With Aphasia

Post-stroke Depression · Post-stroke Aphasia

Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Jul 2024
Primary outcome: Primary: Change in Beck's Depression Inventory, BDI. — -12.6; -5.8 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Intensive communicative-pragmatic social interaction. (Behavioral); Standard care. (Behavioral)
Age
Pediatric, Adult, Older Adult
Sex
All
Sponsor
University Medicine Greifswald
Primary completion
Jan 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Beck's Depression Inventory, BDI.
-12.6; -5.8
PRIMARY
Change in Hamilton Rating Scale for Depression, HAM-D. Higher Values Represent Higher Degree of Depression.
-5.0; -3.3
SECONDARY
Self-Efficacy Questionnaire.
20.1; 18.3

Summary

The present parallel-group, single-center, blinded-assessment controlled trial seeks to explore the feasibility - in terms of high completion rates - and potential efficacy of intensive communicative-pragmatic social interaction for treatment of post stroke depression in subacute aphasia. Apart from evidence of treatment feasibility, the primary hypothesis predicts significantly greater progress on self-report and clinician-rated measures of depression severity after (i) intensive communicative-pragmatic social interaction combined with standard care, compared to (ii) standard care alone.

Eligibility Criteria

Inclusion Criteria

  • Left-hemisphere cortical or subcortical stroke;
  • Native speaker of German;
  • Right-handedness according to the Edinburgh Handedness Inventory (Oldfield, 1971);
  • Diagnosis of post-stroke depression, as defined in the International Statistical Classification of Diseases and Related Health Problems (ICD-11);
  • Diagnosis of aphasia, as confirmed by standardized tests (e.g., Huber et al., 1984); and
  • Late subacute or consolidation phase (i.e., 0.5-6 months following stroke) where risk of post-stroke depression is particularly high (Shi et al., 2014).

Exclusion Criteria

  • Other neurological conditions;
  • Pre-morbid history of depression;
  • Other psychopathological conditions;
  • Severely impaired vision or hearing that may prevent participants from engaging in intensive communicative-pragmatic social interaction during therapy or testing, thus adopting routine-healthcare standards from a large-scale phase-III randomized controlled trial (Breitenstein et al., 2017);
  • Serious non-verbal cognitive deficits; and
  • No informed consent.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04318951). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search